Magnetic resonance imaging (MRI) provides a noninvasive method for studying the fate of transplanted cells in vivo. We studied whether superparamagnetic nanoparticles (CD34 microbeads), used clinically for specific magnetic sorting, can be used as a magnetic cell label for in vivo cell visualization. Human cells from peripheral blood were selected by CliniMACS  CD34 Selection Technology (Miltenyi). Purified CD34 + cells were implanted into rats with a cortical photochemical lesion, contralaterally to the lesion. Twenty-four hours after grafting, the implanted cells were detected in the contralateral hemisphere as a hypointense spot on T 2 weighted images; the hypointensity of the implant decreased during the first week. At the lesion site we observed a hypointensive signal 10 days after grafting that persisted for the next 3 weeks, until the end of the experiment. Prussian blue and anti-human nuclei staining confirmed the presence of magnetically labeled human cells in the corpus callosum and in the lesion 4 weeks after grafting. CD34 + cells were also found in the subventricular zone (SVZ). Human DNA (a human-specific 850 base pair fragment of α-satellite DNA from human chromosome 17) was detected in brain tissue sections from the lesion using PCR, confirming the presence of human cells. Our results show that CD34 microbeads superparamagnetic nanoparticles can be used as a magnetic cell label for in vivo cell visualization. The fact that microbeads coated with different commercially available antibodies can bind to specific cell types opens extensive possibilities for cell tracking in vivo.
INTRODUCTION
tion in the host organism. Methods have now been developed to incorporate sufficient amounts of superparamagnetic contrast agents into cells, enabling their detection During the past two decades, dramatic progress in cellular transplantation and in vivo and ex vivo gene in vivo using magnetic resonance (MR) imaging. Magnetically labeled cells are then visible on T 2 weighted therapy has heightened optimism about future cures for injuries and diseases of the central nervous system (CNS).
images as a hypointensive signal. For the synthesis of the contrast agents, small crystals of magnetite Fe 3 O 4 Some successful therapeutic approaches in animal models (rodents and primates) have already been transferred are predominantly used. The crystals are covered by a macromolecular shell, which can be chemically or bioto the clinical area (11,13). The implantation of therapeutic cells in patients will require techniques that can chemically modified (40, 42, 44, 45) . When specific antibodies are attached to the shell, the contrast agent can noninvasively monitor their fate, behavior, and migra-be specifically bound to tissue [for review see (4)]. Up agent. After washing away the excess unbound reagent, the automated selection was started. The CliniMACS to now, several types of contrast agents with a nanoparticle diameter in the range of 20 to 150 nm have been system passed the antibody-labeled suspension through a column in which strong magnetic gradients were gendescribed, some of which are commercially available (40) .
Bone marrow (BM) cells were reported recently to erated. The column retained the magnetically labeled CD34 + cells, while unwanted cells passed through and selectively target injured brain and spinal cord tissue and promote functional recovery (1, 7, 21, 22, 27, 28) . Some were collected in the negative fraction bag. The system performed several washing steps, disposing of most of BM cells give rise to cells with a neural phenotype (22, 24) . CD34
+ cells-a subset of bone marrow cells-are the liquid into the buffer waste bag. The selected CD34 + cells were released from the column by removing the known as hematopoietic progenitor cells (HPCs) (8). These cells, purified using a Miltenyi MACS sorter, are column from the magnetic field and eluting the cells into the cell collection bag. These highly purified cells were clinically used for hematopoiesis restoration (17, 18, 25) . They are an important tool in clinical medicine, because cryopreserved. The viability of cells after thawing was demonstrated indirectly by means of the cultivation of they are an integral part of the BM transplant protocols used in leukemia therapy. In addition, HPCs can express CFU-GM and CFU-mix using the MethoCult system (StemCell Technologies, Canada). Cryopreservation is neural genes (15) and may be a potential resource for generating neural stem cells in the injured CNS.
routinely performed in our laboratory in the presence of dimethyl sulfoxide (DMSO, Sigma, St. Louis, MO) at a We studied if microbead superparamagnetic nanoparticles, normally used for specific magnetic sorting, can final concentration of 7.5% w/v, using an IceCube 1810 (Sy-Lab, Austria) programmable liquid nitrogen freezer. also be used as a magnetic cell label for in vivo cell visualization. Generally, HPCs can be separated from Photochemical Lesion BM or granulocyte-colony stimulating factor (G-CSF)
We used a photochemical lesion as a model of thrommobilized peripheral blood by means of immunomagbotic stroke (41) . The lesion model uses a photocheminetic selection using anti-CD34 antibodies. For sorting, cal reaction in vivo to induce a thrombosis leading to a microbeads with a superparamagnetic iron-oxide core cerebral infarction. The method is virtually noninvasive coated with a polysaccharide that is linked to an antibecause the skull is translucent for light at 560 nm, body are bound to the respective cell. The selected which is the wavelength used for inducing the photo-CD34 + cells retain the magnetic label attached to their chemical reaction. As a result of the light exposure, surface, and because the size of the microbeads' superRose Bengal is excited and subsequently generates sinparamagnetic core is comparable to the size of the superglet molecular oxygen, thus it has the ability to induce paramagnetic core of MR contrast agents, microbeads photoperoxidative reactions. Damage to lipid membranes may provide sufficient contrast on MR images. The lamay provide the initial stimulus for platelet adhesion beled cells may therefore be visualized as a hypointense and subsequent aggregation, leading to thrombosis and signal on T 2 weighted MR images.
infarction within 1 h (41). The formation of thrombotic plugs and adjacent red blood cell stasis within pial and MATERIALS AND METHODS parenchymal vessels is thus observed within the area exCell Selection posed to the light. CD34 + cells were prepared from human G-CSF mobiWistar male rats, 6-8 weeks old, were used throughlized peripheral blood progenitor cell concentrates using out the study. Animals were divided into two groups: 1) a CliniMACS (Miltenyi Biotech GmbH; Bergisch Gladrats with a cortical photochemical lesion and with contrabach, Germany) system and cryopreserved. The CD34 + laterally grafted CD34 + cells (n = 8), and 2) rats with a cells were obtained from parental donors for patients cortical photochemical lesion and with contralaterally who died before their planned haploidentical transplaninjected phosphate-buffered saline (PBS) (n = 4). tation. The use of the cells for experimental purposes
The rats were anesthetized by isoflurane (2% isoflurwas based on the informed consent of the donors.
ane in air). Rose Bengal, a potent photosensitizing dye, The first peripheral blood progenitor cell (PBPC) harwas injected intravenously into the femoral vein (1 mg/ vest was performed on the fifth day of daily G-CSF ad-100 g). A 1 × 2-mm area of the skull above the right ministration and the second harvest on the sixth day. cortex was exposed to the light from a halogen lamp for The sorting of CD34
+ cells was performed on the sixth 10 min, while the rest of the skull was shielded with day from the pooled PBPCs. The viability of the cells aluminum foil. The skin on the head was sutured, and after cell selection was 99.3%, compared with the viabilthe rats were left to recover and returned to their cages. ity before selection, as measured by flow cytometry. The
Grafting of CD34 + Progenitor Cells yield of the selection procedure was 40%.
For labeling of the CD34 + cells, the leukapheresis Rats were anesthetized with isoflurane (Isofluran, Rhodia Organique Fine Limited, Bristol, UK) 7 days product was incubated with the CliniMACS CD34 Re-
CD34
+ PROGENITOR CELLS AND MR IMAGING 175 after the photochemical lesion and mounted in a stereoby mouse monoclonal anti-human nuclei antibody diluted 1:40 (Chemicon, Tenecula), and by a mouse tactic frame. Using aseptic technique, a burr hole (1 mm) was made on the left side of the skull to expose monoclonal antibody directed against CD34 (clone QBEND10, Immunotech, Co.), diluted 1:100. As a secthe dura overlying the left cortex (22) . Thawed CD34 + progenitor cells (7.5 × 10 6 ) were suspended in 5 µl of ondary antibody goat anti-mouse IgG Alexa 594 (Molecular Probes) was used for the anti-human nuclei PBS and slowly injected over a 10-min period using a Hamilton syringe into the contralateral hemisphere AP assay, and the CD34 antigen-antibody complexes were visualized using a biotin-streptavidin detection system −1 mm, ML 2.5 mm, and DV 3.5 mm from bregma based on the atlas of Paxinos and Watson (30). The (LSAB2 System, HRP, DakoCytomation,) with 3,3′-diaminobenzidine as a chromogen (Fluka Chemie, opening was closed by bone wax and the skin was sutured. For immunosuppression, cyclosporin (Novartis) GmbH.). To visualize the possible colocalization of human nuclei and cell type-specific markers in the same 10 mg/kg IP was injected daily and Depo-Medrol  (UpJohn) was administered weekly. cells, double staining was employed. Sections were incubated with cell type-specific antibodies directed against Magnetic Resonance Imaging neuronal nuclear antigen (NeuN), dilution 1:100 (Chemicon), or against glial fibrilary acidic protein (GFAP) for MR images of the brain were obtained using a 4.7 T Bruker spectrometer equipped with a homemade surface identifying astrocytes, dilution 1:2500 (DAKO), as well as with anti human-nuclei as described above. As a seccoil. The rats were anesthetized by passive inhalation of 1.5-2% isoflurane in air. Breathing was monitored durondary antibody, goat anti-mouse IgG Alexa 488 (Molecular Probes) was used. Host macrophages were deing the measurements. Single sagittal, coronal, and transversal images were obtained by a fast gradient echo tected by ED1 (mouse monoclonal anti-rat monocytes and macrophages FITC conjugate; Biosource internasequence for localizing the subsequent T 2 weighted transversal images measured by a standard turbospin tional, Camarillo, CA), diluted 1:100. To confirm that after cryopreservation microbeads reecho sequence. Sequence parameters were: repetition time T R = 2000 ms, effective echo time T E = 42.5 ms, main attached to the cell surface, electron microscopy was performed. For electron microscopic examination, turbo factor = 4, number of acquisitions AC = 16, field of view FOV = 3.5 cm, matrix 256 × 256, slice thickness thawed CD34 + progenitor cells were fixed at 4°C in 2.5% buffered glutaraldehyde for 1 h, followed by 1% 0.5 mm, slice separation 1 mm. Two sets of interleaved transversal images were measured to cover the whole osmium tetroxide for 2 h. The cells were dehydrated in ascending concentrations of ethanol, immersed in probrain (22) . All animals were scanned once 24 h after lesion induction, then 1, 3, 10, 17, and 28 days after cell pylene oxide, and embedded in Epon 812 resin (Agar Scientific Ltd, Standsted England). The samples were grafting.
To check the sensitivity of the MRI technique, we cut in ultrathin sections (ϳ60 nm). These sections were contrasted with 4% uranyl acetate and Reynold's lead performed in vitro experiments in gelatin. Cell suspensions were suspended in 1.7% gelatin at final concentracitrate and examined in a Philips Morgagni 268 transmission electron microscope. tions of 97,000, 48,500, 24,250, 12,100, 6050, 3000, 1500, or 750 cells/µl. Samples, together with a gelatinIron Content Quantitative Analysis only control, were scanned using a 4.7 T Bruker spectrometer. Phantoms containing labeled cells were mea-
The amount of iron present in the cells was determined after mineralization by spectrophotometry. Samsured by a similar T 2 weighted sequence with a different geometry: field of view FOV = 6 cm, matrix 256 × 256, ples (2 ml) containing 6 × 10 7 cells were mineralized after the addition of 5 ml HNO 3 and 1 ml H 2 O 2 in an slice thickness 1 mm. Only one slice was measured in the case of phantoms.
ETHOS 900 microwave mineralizator (Millestone ETHOS 900, Sydney, Australia). Deionized water was added to Histology and Immunohistochemistry reach a total volume of 100 ml. The iron content was determined using a Spectroflame M120S (Spectro Inc., Rats were sacrificed 4 weeks after transplantation. The animals were deeply anaesthetized with chloral hyLittleton, MA) calibrated with a standard solution of Astasol (Analytika Ltd., Prague, Czech Republic). The drate; their chest was opened and transcardially perfused with physiological saline followed by 4% paraformaldemeasurements were repeated four times, and the average value was determined. hyde in phosphate buffer (pH 7.4). Fixed brains were dissected and immersed in PBS with 30% sucrose. Fro-DNA Polymerase Chain Reaction zen coronal sections (40 µm) were cut through the whole brain.
Genomic DNA was extracted from rat brains using the Wizard Genomic DNA Purification Kit (Promega Transplanted CD34
+ cells were detected by staining for iron to produce ferric ferrocyanide (prussian blue), Corporation, USA) according to the manufacturer's in-structions. The presence of human-specific DNA within concentration in a 100-ml sample containing 7.28 × 10 7 cells was 0.2 µg/ml, which corresponds to an average the rat brains was confirmed by polymerase chain reaction amplification of a 850-bp fragment of the α-satellite value of 0.275 pg of iron per cell. This value is lower by an order of magnitude than in the case of cell labeling region of human chromosome 17 using primers corresponding to the primer pair 17a1/17a2 as described by using other contrast agents that enter the cell ( (Fig. 2B) . The hyperintensity is caused for 1 min each were performed, followed by a final exby an acute edema. In control (nonimplanted) animals tension step at 72°C for 10 min. Amplified DNA fragthe lesion remained visible during the whole experimenments were electrophoresed through 1.75% agarose gels tal period as an inhomogeneity in the tissue texture (Fig. and subsequently visualized through ultraviolet light 2C). In brains with a photochemical lesion and contralatafter staining with ethidium bromide. Genomic DNA erally injected cells, the cell implants were clearly visisamples from peripheral blood leukocytes of healthy ble 24 h after grafting as a hypointense area at the injecvolunteers, as positive controls, and PCR quality water, tion site (Fig. 2D) . The hypointense signal of the injected as a negative control, were processed in parallel. Leukocell implant is caused by the magnetic label bound to cytes were isolated from whole blood by lysing erythrothe cell surface, because the label behaves as a supercytes using FACS lysing solution (BD, San Jose, CA) paramagnetic MR contrast agent. The hypointensity of then washing two times with sterile PBS. the implant decreased during the first week (Fig. 2E ) but All animal experiments were carried out in accorremained visible for the entire measurement period. Ten dance with the European Communities Council Direcdays after grafting we observed a weak hypointense sigtive of November 24, 1986 (86/609/EEC). nal in the lesion (Fig. 2F ) that persisted for the next 3 weeks (i.e., until the end of our observation period) (Fig.  RESULTS  2G) , thus suggesting the presence of magnetically la-
Labeling of CD34
+ Progenitor Cells With Microbeads beled cells in the lesion. The cells were selected from human peripheral blood Histology. Four weeks after grafting, histology progenitor cell concentrates by means of immunomagshowed that prussian blue-positive cells and cells stained netic selection using a CliniMACS system (Miltenyi).
for human nuclei had entered the lesion (Fig. 1C, E) , Unlike the nanoparticles of the contrast agent Endorem, confirming the presence of magnetically labeled human which enter the cell and thus are present in the cell cytocells in the lesion. Many labeled cells were also detected plasm (22, 23) , the microbeads are bound to the cell surin the corpus callosum, suggesting a migration route face via antigen-antibody interaction. Therefore, we from the contralateral hemisphere towards the lesion. first determined that after cryopreservation, the microWhen we used a mouse monoclonal antibody directed beads remain bound to the cell surface. Transmission against CD34, CD34 + cells were detected not only in the electron microscopy confirmed the presence of several corpus callosum and in the lesion, but also in the SVZ iron oxide nanoparticles attached to the cell surface. (Fig. 1F) . (Fig. 1A, B) .
Polymerase Chain Reaction. Brain tissue sections In Vitro MRI Detection of CD34
+ Progenitor Cells from the injection site, from the lesioned area, and from PBS-injected animals were tested using the polymerase In vitro measurements of cell suspensions in gelatin chain reaction (PCR) to detect a human-specific 850 showed a visibly hypointense signal on MRI with cell base pair fragment of α-satellite DNA from human chroconcentrations of 6050 cells/µl and higher ( Fig. 2A) . mosome 17. Human DNA was detected in the lesion of Image voxel volume [i.e., the sample volume that prografted animals. No human-specific DNA was detected duces a signal of one image pixel (in a 1-mm slice with in PBS-injected animals (Fig. 3) . planted stem cells in a host organism. In our previous have reported that it is possible to visualize magnetically labeled cells in the brain or spinal cord after transplantastudies we monitored bone marrow stromal cells and mouse embryonic stem cells labeled with the contrast tion (4,6,12,20,26). However, all the magnetic labels (mainly different types of modified contrast agents) emagent Endorem and grafted into rats with a brain or spinal cord injury (22,23) . Similarly, several other groups ployed were intracellular. To enter the cell, different CD34 + PROGENITOR CELLS AND MR IMAGING 179 agent); they provide sufficient MR contrast although the average iron content per cell is an order of magnitude lower than in the case of cell labeling with Endorem and other contrast agents that enter the cell (22) . The data obtained from MR correlated with histological findings. PCR confirmed the presence of human cells in the lesion. To exclude that loose microbeads were taken up by macrophages, we performed ED1 staining for activated microglia/macrophages. Although we found strong ED1 positivity in the lesions, prussian blue staining did not colocalize with ED1 staining (Fig. 1C, D) . In studies in which macrophage infiltration in different central nervous system disorders has been visualized with ultrasmall superparamagnetic iron oxide particles (USPIO) (9,10,32,34), the time course of loading macrophages with USPIO and their subsequent visualization on MR images did not correspond with the changes in MRI signal observed in our experiments. In rats (9,10, 32,34), as well as in humans (31,38), a low intensity signal in the lesion due to infiltrating macrophages loaded with USPIO was already visible on T 2 weighted images at 24-72 h after the injection of USPIO into the blood stream, while in our experiments we observed a hypointensive signal in the lesion 10 days after grafting. Therefore, if the label were released in vivo and taken ing the 7 days prior to cell grafting.
Bone marrow as an alternative source of adult stem cells may have practical advantages over embryonic methods to facilitate entry are often required (e.g., lipostem cells and has been proposed for use as a source of fection, transfection agents, antibody-iron oxide particle autologous grafts. HPCs (characterized by the presence constructs). Moreover, while commercially available of the CD34 antigen) represent a major focus of current contrast agents are clinically approved as blood pool research (14,43). These cells have the capacity for exagents, to be used as markers of implanted cells for clintensive self-renewal and pluripotent differentiation and ical use in stem cell therapies further testing for cell are used therapeutically to provide long-term bone martoxicity and verification of CNS tolerance has to be row reconstitution in patients suffering from some leudone. In contrast, the microbeads used for immunomagkemias, lymphomas, solid tumors, aplastic anemias, and netic selection remain attached to the surface of a spemetabolic disorders (19) . Furthermore, human CD34 + cific cell after sorting and have been safely transplanted cell have been shown to secrete numerous angiogenic into patients with hematological diseases (17, 18) . Bulte factors, including VEGF, HGF, and IGF-1 (29) . On the et al. (5) described experiments with human lymphobasis of these observations, clinical trials of cell transcytes labeled with biotinylated antilymphocyte-directed plantation in hindlimb (35, 37) and cardiac ischemia (16) monoclonal antibodies, to which streptavidin and subsehave been initiated with promising results. Human quently biotinylated dextran-magnetite particles were CD34 + cells can be collected from BM, cord blood, or coupled. Similar to our results, labeled lymphocyte susfrom peripheral blood after cytokine mobilization. In our pensions enhanced negative contrast, though the experistudy we grafted human CD34 + progenitor cells, obments were done in a weaker magnetic field (2.0 Tesla).
tained from peripheral blood after G-CSF stimulation, However, the study was done only in vitro, and the lainto the lesioned rat brain. The human cells migrated beling kit used is not commercially available. In our from the injection site to the lesion and to the SVZ, study we confirmed that CD34 microbeads can be used where they survived throughout our observation period as a magnetic label (a highly specific MR contrast of 1 month. Our results are in agreement with the find- Animal studies indicate that improved neural func-
